Policy & Regulation
Egle identifies first Treg targets in research alliance with Takeda
27 November 2020 - Emerging biotechnology company Egle Therapeutics has achieved the first milestone in its strategic research alliance with Japan's Takeda Pharmaceutical Company Limited (TYO:450...
Golden Biotechnology announces positive results for Antroquinonol phase two clinical study
27 November 2020 - Golden Biotechnology Corporation (4132.TWO), a Taiwan-based biopharmaceutical company, has revealed that its Antroquinonol, a new drug intended to treat acute myeloid leukaemia (AML...
Pfizer Doses First Participant in Phase 3 Study Evaluating anti-TFPI Investigational Therapy, Marstacimab, for People with Severe Hemophilia A and B with or Without Inhibitors
27 November 2020 - - US-based biopharmaceutical company Pfizer Inc. (NYSE: PFE) has dosed first participant in the Phase 3 BASIS study of marstacimab (PF-06741086), an anti-tissue factor pathway inhib...
Merck Submits Applications in US, Europe for Licensure of Investigational 15-valent Pneumococcal Conjugate Vaccine
27 November 2020 - - US-based pharmaceutical company Merck (NYSE: MRK) has submitted applications to the US Food and Drug Administration and European Medicines Agency for licensure of V114, Merck'...
Russia's RDIF agrees to produce over 100 million doses annually of its Sputnik V COVID-19 vaccine in India
27 November 2020 - Russia's sovereign wealth fund, the Russian Direct Investment Fund (RDIF), and Indian pharmaceutical company Hetero have agreed to produce over 100 million doses per year in In...
COVAXX signs advanced purchase commitments worth USD2.8bn for COVID-19 vaccine
26 November 2020 - Vaccine development company COVAXX, a subsidiary of United Biomedical Inc, said on Wednesday that it has agreed advanced purchase commitments for more than 140 million doses of its ...
Related Headlines

RedHill Biopharma collaborates with two US-based manufacturers for large-scale Opaganib production

Celltrion Completes Enrolment for Global Phase II Clinical Trial with COVID-19 Treatment Candidate CT-P59

FDA Defers Approval of DaxibotulinumtoxinA for Injection in Glabellar Lines Due to COVID-19 Related Travel Restrictions Impacting Manufacturing Site Inspection

European Commission's Approves Advance Purchase Agreement for Initial 80m Doses of Moderna mRNA COVID-19 Vaccine

Bristol Myers Squibb Receives European Commission Approval for Opdivo as Second-Line Treatment for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Vedanta Biosciences Names Karuna Therapeutics CFO Ignelzi to Its Board of Directors

US Food and Drug Administration Approves Oxlumo for Primary Hyperoxaluria Type 1 to Lower Urinary Oxalate Levels in Pediatric and Adult Patients

Study reveals that mutations not making COVID-19 virus able to spread more rapidly

BioNTech and Fosun commence Phase II trial of BioNTech's COVID-19 vaccine in China

Oramed Pharmaceuticals screens first patients in global Phase three trials of ORMD-0801

Integral Molecular launches fully optimised, high-affinity lead monoclonal antibodies against Claudin 18.2

Ascentage Pharma doses first patient in Phase Ib/II clinical study of APG-2575 in Ukraine

US government's Operation Warp Speed reviewing AstraZeneca's COVID-19 vaccine data to see if efficacy can be improved

Phase 2a Study of Vibegron for the Treatment of Irritable Bowel Syndrome Pain Did Not Meet Primary Endpoint

Appili Therapeutics Starts New Phase 3 Clinical Trial to Evaluate Avigan Tablets in the Prevention of COVID-19